Exploring the latest breakthroughs in partial reprogramming using OSKM factors for anti-aging, with insights from mouse studies and early clinical trials for eye diseases. Recent studies show partial ...
Recent studies show micro- and nanoplastics are found in human tissues, potentially speeding up aging via oxidative stress and inflammation, with gaps in human data needing urgent research. New resear...
Recent research demonstrates how reduced protein intake promotes white fat browning through gut bacteria interactions, mimicking calorie restriction effects for potential obesity and aging therapies. ...
Stanford University researchers have engineered NK and T cells with metabolite-sensing receptors like GPR183, enhancing tumor infiltration in mice and offering new hope for CAR-T therapies in solid tu...
Recent studies show α-eleostearic acid and its methyl ester induce ferroptosis in senescent cells, reducing inflammation and improving muscle function in aged mice without toxicity, with clinical tri...
Recent research shows probiotics and fecal microbiota transplantation reduce neuroinflammation via the gut-brain axis, offering promising therapies for neurodegenerative diseases with clinical trials ...
Recent studies show encapsulated mitochondria delivery using red blood cell membranes improves motor function and neuron survival in Parkinson’s disease models, offering hope for mitochondrial d...
Senolytic and senomorphic therapies, including Rubedo’s RLS-1496 in Phase 1 trials, target senescent cells to treat aging diseases, boosted by AI-driven discovery and rising investment. New seno...
New mitochondrial transplantation via red blood cell encapsulation shows 50% efficiency boost and improved motor function in Parkinson’s models, with FDA fast-tracking clinical trials. Recent st...
Senolytic and senomorphic therapies are advancing with compounds like RLS-1496 and α-ESA-me targeting senescent cells. Experts highlight challenges in biomarkers and safety, pushing for personalized ...
